The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Phenyl-6-(4-(2-(trifluoromethyl)benzoyl)piperazin-1-yl)-pyridazine-3-carboxamide ID: ALA2315103
PubChem CID: 66849498
Max Phase: Preclinical
Molecular Formula: C23H20F3N5O2
Molecular Weight: 455.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccccc1)c1ccc(N2CCN(C(=O)c3ccccc3C(F)(F)F)CC2)nn1
Standard InChI: InChI=1S/C23H20F3N5O2/c24-23(25,26)18-9-5-4-8-17(18)22(33)31-14-12-30(13-15-31)20-11-10-19(28-29-20)21(32)27-16-6-2-1-3-7-16/h1-11H,12-15H2,(H,27,32)
Standard InChI Key: XILJDMHVCGVOES-UHFFFAOYSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
3.4031 -27.4747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2203 -27.4753 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6295 -26.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4467 -26.7686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2214 -26.0599 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8522 -27.4752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6686 -27.4762 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0786 -26.7683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6662 -26.0579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8511 -26.0604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8961 -26.7694 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3039 -27.4787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1175 -27.4802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5295 -26.7741 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1218 -26.0648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3020 -26.0616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3467 -26.7767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7530 -27.4857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7576 -26.0703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.3391 -28.1887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7447 -28.8972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5628 -28.9003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9735 -28.1890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5656 -27.4833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9729 -26.7749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7901 -26.7734 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.5630 -26.0679 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.3734 -26.0634 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.0009 -26.7666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1844 -26.7656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7745 -27.4735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1869 -28.1839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0020 -28.1814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
3 5 2 0
4 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 4 1 0
11 12 1 0
11 16 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
8 11 1 0
14 17 1 0
17 18 1 0
17 19 2 0
18 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 18 1 0
24 25 1 0
25 26 1 0
25 27 1 0
25 28 1 0
1 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 1 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 455.44Molecular Weight (Monoisotopic): 455.1569AlogP: 3.71#Rotatable Bonds: 4Polar Surface Area: 78.43Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.36CX LogP: 3.76CX LogD: 3.76Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.65Np Likeness Score: -2.07
References 1. Zhang Z, Sun S, Kodumuru V, Hou D, Liu S, Chakka N, Sviridov S, Chowdhury S, McLaren DG, Ratkay LG, Khakh K, Cheng X, Gschwend HW, Kamboj R, Fu J, Winther MD.. (2013) Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome., 56 (2): [PMID:23245208 ] [10.1021/jm301661h ] 2. Llona-Minguez S, Höglund A, Ghassemian A, Desroses M, Calderón-Montaño JM, Burgos Morón E, Valerie NCK, Wiita E, Almlöf I, Koolmeister T, Mateus A, Cazares-Körner C, Sanjiv K, Homan E, Loseva O, Baranczewski P, Darabi M, Mehdizadeh A, Fayezi S, Jemth AS, Warpman Berglund U, Sigmundsson K, Lundbäck T, Jenmalm Jensen A, Artursson P, Scobie M, Helleday T.. (2017) Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors., 60 (10): [PMID:28508636 ] [10.1021/acs.jmedchem.7b00182 ]